References
- Pistoia V, Morandi F, Bianchi G, Pezzolo A, Prigione I, Raffaghelo L. Immunosuppressive microenvironment in neuroblastoma. Front Oncol 2013; 3:167; PMID:23805414; http://dx.doi.org/10.3389/fonc.2013.00167
- Morris SM Jr. Recent advances in arginine metabolism: roles and regulation of the arginases. Br J Pharm 2009; 15:922-30; PMID:19508396; http://dx.doi.org/10.1111/j.1476-5381.2009.00278.x
- Rodriguez PC, Quiceno DG, Ochoa AC. L-arginine availability regulates T lymphocyte cell-cycle progression. Blood 2007; 109:1568-73; PMID:17023580; http://dx.doi.org/10.1182/blood-2006-06-031856
- Zea AH, Rodriguez PC, Culotta KS, Hernandez CP, DeSalvo J, Ochoa JB, Park HJ, Zabaleta J, Ochoa AC. L-arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes. Cell Immunol 2004; 232:21-31; PMID:15922712; http://dx.doi.org/10.1016/j.cellimm.2005.01.004
- Mussai F, De Santo C, Cerundolo V. Interaction between iNKT cells and MDSCs in cancer patients: Evidence and Therapeutic Opportunities. J Immunother 2012; 35:449-59; PMID:22735803; http://dx.doi.org/10.1097/CJI.0b013e31825be926
- Mussai F, Egan S, Hunter S, Webber H, Fisher J, Wheat R, McConville C, Sbirkov Y, Wheeler K, Bendle G et al. Neuroblastoma arginase activity creates an immunosuppressive microenvironment that impairs autologous and engineered immunity. Cancer Res 2015; 75(15):3043-53; PMID:26054597; http://dx.doi.org/10.1158/0008-5472.CAN-14-3443
- Mussai F, De Santo C, Abu-Dayyeh I, Booth S, Quek L, McEwen-Smith RM, Qureshi A, Dazzi F, Vyas P, Cerundolo V. Acute Myeloid leukaemia creates an arginase dependent immuno-suppressive microenvironment. Blood 2013; 122:749-58; PMID:23733335; http://dx.doi.org/10.1182/blood-2013-01-480129
- Krishnadas DK, Shusterman S, Bai F, Diller L, Sullivan JE, Cheerva AC, George RE, Lucas KG. A Phase I trial combining decitabine/dendritic cll vaccine targeting MAGE-A!, MAGE-A3 and NY-ESO for children with relapsed or therapy refractory neuroblastoma and sarcoma. Cancer Immunol Immunother 2015; 64(10):1251-60; PMID:26105625; http://dx.doi.org/10.1007/s00262-015-1731-3
- Louis CU, Savoldo B, Dotti G, Pule M, Yvon E, Myers GD, Rossig C, Russell HV, Diouf O, Liu E et al. Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma. Blood 2011; 118(23):6050-6; PMID:21984804; http://dx.doi.org/10.1182/blood-2011-05-354449
- Ivanenkov YA, Chufarova NV. Small-molecule arginase inhibitors. Pharm Pat Anal 2014; 3(1):65-85; PMID:24354980; http://dx.doi.org/10.4155/ppa.13.75